期刊文献+

加味四磨汤治疗慢性阻塞性肺疾病稳定期合并焦虑障碍临床研究 被引量:4

Clinical Study on Modified Simo Decoction for Stable Phase of COPD Complicated with Anxiety Disorder
下载PDF
导出
摘要 目的观察加味四磨汤治疗慢性阻塞性肺疾病稳定期合并焦虑障碍的疗效。方法治疗组运用加味四磨汤配合舍曲林胶囊治疗52例,对照组单用舍曲林胶囊治疗48例。结果中医证候、焦虑症状、营养状况、呼吸量表2组比较存在显著差异(P<0.01)。结论加味四磨汤治疗慢性阻塞性肺疾病稳定期合并焦虑障碍有显著疗效。 Objective To evaluate the therapeutic effect of modified Simo decoction for stable phase of COPD complicated with anxiety disorder. Methods 52 cases in the treatment group were treated by modified Simo decoction and Sertraline capsules, and other 48 cases were treated by Sertraline capsules individually as the contrast group. Results It was obvious of the discrepancy for TCM syndrome, anxiety symptom, nutriture and pneumatometer between the two groups(P 0.01). Conclusion Modified Simo decoction is an effective prescription in the treatment of stable phase of COPD complicated with anxiety disorder.
作者 陈新 车德亚
出处 《中国中医药现代远程教育》 2016年第15期63-64,共2页 Chinese Medicine Modern Distance Education of China
基金 四川省科技计划项目(No:2014sz0215)
关键词 加味四磨汤 慢性阻塞性肺疾病 焦虑障碍 中西医结合疗法 肺胀 modified Simo decoction COPD anxiety disorder therapy of integrated medicine lung-distention
  • 相关文献

参考文献6

  • 1Busch AM, Scott-Sheldon LA, Pierce J, et al. Depressed mood predicts pul- monary rehabilitation completion among women, but not men. Respir Med 2014,108(7):1007-13.
  • 2Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronie Obstructive Lung Disease (GOLD) .Revised 2016.
  • 3蔡闯,钟南山.慢性阻塞性肺疾病与焦虑抑郁的关系[J].中华结核和呼吸杂志,2007,30(1):71-72. 被引量:81
  • 4冯丹,杨汀.合并焦虑抑郁对慢性阻塞性肺疾病患者的影响[J].中国医药,2014,9(12):1856-1858. 被引量:7
  • 5沈映君.中药药理鞠[J].上海止海科技出版社,2001:109-110,129-130,163-164.
  • 6雷载权.中药学[M].上海:上海科学技术出版社,1998.251,259,58,193.

二级参考文献56

  • 1Brenes GA.Anxiety and chronic obstructive pulmonary disease:prevalence,impact,and treatment.Psychosom Med,2003,65:963-970.
  • 2Chetta A,Foresi A,Marangio E,et al.Psychological implications of respiratory health and disease.Respiration,2005,72:210-215.
  • 3Kunik ME,Roudy K,Veazey C,et al.Surprisingly high prevalence of anxiety and depression in chronic breathing disorders.Chest,2005,127:1205-1211.
  • 4van Ede L,Yzermans C J,Brouwer HJ.Prevalence of depression in patients with chronic obstructive pulmonary disease:a systematic review.Thorax,1999,54:688-692.
  • 5Di Marco F,Verga M,Reggente M,et al.Anxiety and depression in COPD patients:the roles of gender and disease severity.Respir Med,2006,100:1767-1774.
  • 6Norwood R.Prevalence and impact of depression in chronic obstructive pulmonary disease patients.Curr Opin Pulm Med,2006,12:113-117.
  • 7Kim HF,Kunik ME,Molinari VA,et al.Functional impairment in COPD patients the impact of anxiety and depression.Psychosomatics,2000,41:465-471.
  • 8Dahlen I,Janson C.Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease.Chest,2002,122:1633-1637.
  • 9Roundy K,Cully JA,Stanley MA,et al.Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A Chart review.Prim Care Companion J Clin Psychiatry,2005,7:213-218.
  • 10Smoller JW,Pollack MH,Systrom D,et al.Sertraline effects on dyspnea in patients with obstructive airways disease.Psychosomatics,1998,39:24-29.

共引文献200

同被引文献77

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部